首页> 外文期刊>Psychopharmacology >Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers.
【24h】

Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers.

机译:比较抗抑郁药瑞波西汀,氟伏沙明和阿米替林对健康志愿者自发性瞳孔波动的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

RATIONALE: Spontaneous fluctuations in the size of the pupil in darkness are a recognised index of "sleepiness". OBJECTIVE: To evaluate the effects of single oral doses of three antidepressants: reboxetine (4 mg), a selective noradrenaline reuptake inhibitor, fluvoxamine (100 mg), a selective serotonin reuptake inhibitor, and amitriptyline (100 mg), a tricyclic antidepressant of known sedative property, upon spontaneous pupillary fluctuations in healthy male volunteers (n=16). METHODS: Using the recently developed pupillographic sleepiness test (PST), resting pupil diameter was recorded and two measures of pupillary fluctuations were obtained: total power obtained from a fast Fourier transform and spectral analysis, and the pupillary unrest index (PUI), a cumulative measure of changes in pupil size. Subjects also rated themselves on a battery of visual analogue scales for "alertness", "anxiety" and "contentedness". RESULTS: Resting pupil diameter was enhanced by reboxetine, but remained unaffected by the other two antidepressants. Amitriptyline, consistent with its sedative property, increased the total power of pupillary fluctuations and showed a tendency to increase PUI. These pupillary effects of amitriptyline were paralleled by reduced scores on the "alertness", "contentedness" and "anxiety" self ratings. Neither fluvoxamine nor reboxetine affected pupillary fatigue waves or subjective ratings of "alertness". Reboxetine caused a small reduction in subjectively rated "anxiety". CONCLUSIONS: The mydriatic effect of reboxetine may be due to noradrenaline reuptake blockade in the iris and/or in the central nervous system. The enhancement of pupillary fatigue waves by the sedative antidepressant amitriptyline, but not by the non-sedative antidepressants fluvoxamine and reboxetine, indicates that the PST is a suitable quantitative objective test for the detection of drug-induced changes in the level of arousal.
机译:理由:黑暗中瞳孔大小的自发波动是公认的“困倦”指标。目的:评估单次口服三种抗抑郁药的作用:瑞波西汀(4 mg),选择性去甲肾上腺素再摄取抑制剂,氟伏沙明(100 mg),选择性5-羟色胺再摄取抑制剂和阿米替林(100 mg)(已知的三环抗抑郁药)在健康男性志愿者中自发的瞳孔波动时具有镇静作用(n = 16)。方法:使用最近开发的瞳孔嗜睡测试(PST),记录静息瞳孔直径并获得两种测量瞳孔波动的方法:通过快速傅立叶变换和光谱分析获得的总功率,以及瞳孔不稳指数(PUI),累积测量瞳孔大小的变化。受试者还用一系列视觉模拟量表对自己的“警觉”,“焦虑”和“满足感”进行评分。结果:瑞波西汀可增加静息瞳孔直径,但不受其他两种抗抑郁药的影响。阿米替林与其镇静作用相一致,增加了瞳孔波动的总功率,并显示出增加PUI的趋势。阿米替林的这些瞳孔效应与“警觉性”,“满足感”和“焦虑”自评的分数降低同时出现。氟伏沙明和瑞波西汀均不影响瞳孔疲劳波或主观“警觉”等级。瑞波西汀引起主观评分“焦虑”的轻微降低。结论:瑞波西汀的散瞳作用可能是由于虹膜和/或中枢神经系统中去甲肾上腺素再摄取阻滞所致。镇静抗抑郁药阿米替林可增强瞳孔疲劳波,但非镇静抗抑郁药氟伏沙明和瑞波西汀不能增强瞳孔疲劳波,这表明PST是检测药物引起的觉醒水平变化的合适的定量客观测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号